Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis

Table 4 Results of this meta-analysis

Outcomes analyzed	OR with 95% CI	P value	I² (%)	Fixed or random effects model used
Mortality	1.13 [0.65–1.96]	0.66	0	Fixed
Cardiac death	1.16 [0.50–2.68]	0.74	0	Fixed
Recurrent MI	1.32 [0.88–2.12]	0.18	28	Fixed
TVR	1.36 [0.88–2.12]	0.17	0	Fixed
TLR	1.22 [0.72–2.06]	0.46	0	Fixed
MACEs	1.29 [0.89–1.85]	0.17	0	Fixed
Stroke	1.47 [0.44–4.89]	0.53	0	Fixed

Abbreviations: MI myocardial infarction, TVR target vessel revascularization, TLR target lesion revascularization, MACEs major adverse cardiac events, OR odds ratios, CI confidence intervals

ISSN: 1471-2261